| 000 | 01842 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250517052156.0 | ||
| 264 | 0 | _c20151014 | |
| 008 | 201510s 0 0 eng d | ||
| 022 | _a1476-4687 | ||
| 024 | 7 |
_a10.1038/nature15369 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJaunmuktane, Zane | |
| 245 | 0 | 0 |
_aEvidence for human transmission of amyloid-β pathology and cerebral amyloid angiopathy. _h[electronic resource] |
| 260 |
_bNature _cSep 2015 |
||
| 300 |
_a247-50 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAlleles |
| 650 | 0 | 4 |
_aAlzheimer Disease _xetiology |
| 650 | 0 | 4 |
_aAmyloid beta-Peptides _xadministration & dosage |
| 650 | 0 | 4 | _aAutopsy |
| 650 | 0 | 4 |
_aBlood Vessels _xmetabolism |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 |
_aCerebral Amyloid Angiopathy _xetiology |
| 650 | 0 | 4 |
_aCreutzfeldt-Jakob Syndrome _xcomplications |
| 650 | 0 | 4 | _aDrug Contamination |
| 650 | 0 | 4 |
_aEndothelium, Vascular _xmetabolism |
| 650 | 0 | 4 |
_aGray Matter _xmetabolism |
| 650 | 0 | 4 |
_aHuman Growth Hormone _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIatrogenic Disease |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPrions _xadministration & dosage |
| 650 | 0 | 4 | _aRisk Factors |
| 700 | 1 | _aMead, Simon | |
| 700 | 1 | _aEllis, Matthew | |
| 700 | 1 | _aWadsworth, Jonathan D F | |
| 700 | 1 | _aNicoll, Andrew J | |
| 700 | 1 | _aKenny, Joanna | |
| 700 | 1 | _aLaunchbury, Francesca | |
| 700 | 1 | _aLinehan, Jacqueline | |
| 700 | 1 | _aRichard-Loendt, Angela | |
| 700 | 1 | _aWalker, A Sarah | |
| 700 | 1 | _aRudge, Peter | |
| 700 | 1 | _aCollinge, John | |
| 700 | 1 | _aBrandner, Sebastian | |
| 773 | 0 |
_tNature _gvol. 525 _gno. 7568 _gp. 247-50 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/nature15369 _zAvailable from publisher's website |
| 999 |
_c25246203 _d25246203 |
||